Hearing on "The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases"
The Subcommittee on Health of the Committee on Energy and Commerce held a hybrid hearing that included both in-person and remote attendance on Thursday, July 29, 2021, at 11:00 a.m. This hearing took place in the John D. Dingell Room, 2123 of the Rayburn House Office Building, as well as remotely using Cisco Webex online video conferencing. The hearing is entitled, "The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases."
Key Documents
Memorandum from Chairman Pallone to the Subcommittee on Health
Opening Statement from Chairman Pallone as prepared for delivery
Opening Statement from Subcommittee Chairwoman Eshoo as prepared for delivery
Livestream
Witnesses
Panel I
Patrizia Cavazzoni, M.D.
Director, Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Richard J. Hodes, M.D.
Director, National Institute on Aging
National Institute of Health
Walter J. Koroshetz, M.D.
Director, National Institute of Neurological Disorders and Stroke
National Institute of Health
Testimony of the National Institute of Health
Panel II
Jinsy Andrews, M.D.
Director of Neuromuscular Clinical Trials
Neurological Institute of New York
Associate Professor of Neurology
Columbia University Vagelos College of Physicians and Surgeons
Kala Booth
Huntington's Disease Caregiver and Patient
Merit Cudkowicz, M.D.
Director, Sean M. Healy and AMG Center for ALS
Chief, Neurology Department
Massachusetts General Hospital
Julianne Dorn Professor of Neurology
Harvard Medical School
Cartier Esham, Ph.D.
Executive Vice President, Emerging Companies
Senior Vice President, Science and Regulatory Affairs
Biotechnology Innovation Organization
Yvonne Latty
Caregiver
Brian Wallach
Co-Founder
I AM ALS